The European Society of Cardiology (ESC) has published a series of guidelines on heart
failure (HF) over the last 25 years, most recently in 2016. Given the amount of new …

Aims Guidelines on how to diagnose and treat patients with heart failure (HF) are published
regularly. However, many patients do not fulfil the diagnostic criteria and are not treated with …

Background Heart failure (HF) is a global challenge, with lower-and middle-income
countries (LMICs) carrying a large share of the burden. Treatment for HF with reduced …

Chronic heart failure (CHF) is associated with a heavy burden of disease for patients and
healthcare professionals. Quality of life and long-term prognosis for affected patients remain …

RH4W it has been shown that the outcome of disease may be favourably influenced by the
thorough application of clinical recommendations. Surveys and registries are needed to …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Aim Persistent symptoms despite guideline‐directed medical therapy (GDMT) and poor
tolerance of GDMT are hallmarks of patients with advanced heart failure (HF) with reduced …

The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Aims In older patients, guideline‐directed medical therapy (GDMT) for heart failure (HF) with
reduced ejection fraction (< 40%; HFrEF) is not contraindicated, but adherence to guidelines …

Abstract Aims The European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐
HF‐LT‐R) was set up with the aim of describing the clinical epidemiology and the 1‐year …